Janus Henderson Horizon Biotechnology Fund GU2 EUR
WKN A40QHM | ISIN LU2900275194 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU1540961759 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD | +3,02 % | +18,69 % | 0,05 |
|
| 2 | LU1897414642 | Janus Henderson Horizon Biotechnology Fund E2 USD | +1,03 % | +27,63 % | -0,04 |
|
| 3 | LU2026682919 | Candriam Equities L Biotechnology, V2 - Capitalisation | +3,74 % | +20,67 % | 0,08 |
|
| 4 | LU1540962054 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD | +2,49 % | +19,52 % | 0,02 |
|
| 5 | LU0942225912 | Candriam Equities L Biotechnology, R - Capitalisation | +1,09 % | +20,63 % | -0,05 |
|
| 78 | LU0767968745 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating | -9,31 % | +12,16 % | -0,94 |
|
| 79 | DE000A3DCA95 | BIT Biotech Opportunities S | -30,85 % | +30,97 % | -1,07 |
|
| 80 | LU0415392835 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating | -13,32 % | +14,06 % | -1,10 |
|
| 81 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -30,96 % | +30,96 % | -1,07 |
|
| 82 | LU0415392595 | Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating | -13,93 % | +14,06 % | -1,14 |
|